ARMP Financial Statements

Balance sheet, income statement, cash flow, and dividends for Armata Pharmaceuticals Inc (ARMP).


$66.94M Market Cap.

As of 03/21/2025 5:00 PM ET (MRY) • Disclaimer

ARMP Market Cap. (MRY)


ARMP Shares Outstanding (MRY)


ARMP Assets (MRY)


Total Assets

$86.44M

Total Liabilities

$134.46M

Total Investments

$0

ARMP Income (MRY)


Revenue

$5.17M

Net Income

-$18.92M

Operating Expense

$47.61M

ARMP Cash Flow (MRY)


CF Operations

-$37.55M

CF Investing

-$1.88M

CF Financing

$34.96M

ARMP Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ARMP Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$86,437,000 (-12.12%)

$98,363,000 (2.64%)

$95,834,000 (37.36%)

$69,768,000 (76.56%)

Assets Current

$11,308,000 (-40.95%)

$19,151,000 (-29.19%)

$27,047,000 (80.37%)

$14,995,000 (38.25%)

Assets Non-Current

$75,129,000 (-5.15%)

$79,212,000 (15.16%)

$68,787,000 (25.59%)

$54,773,000 (91.05%)

Goodwill & Intangible Assets

$3,490,000 (0.00%)

$3,490,000 (0.00%)

$3,490,000 (0.00%)

$3,490,000 (0.00%)

Shareholders Equity

-$48,019,000 (-49.76%)

-$32,065,000 (-188.87%)

$36,080,000 (42.06%)

$25,397,000 (34.68%)

Property Plant & Equipment Net

$54,928,000 (-4.10%)

$57,276,000 (22.77%)

$46,652,000 (22.54%)

$38,072,000 (196.58%)

Cash & Equivalents

$14,771,000 (-23.24%)

$19,243,000 (-7.54%)

$20,812,000 (81.16%)

$11,488,000 (5.89%)

Accumulated Other Comprehensive Income

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Deferred Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Investments

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$744,000 (-77.88%)

$3,363,000 (-60.58%)

$8,531,000 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,055,000 (-63.88%)

$5,689,000 (-5.72%)

$6,034,000 (165.81%)

$2,270,000 (17.68%)

Accumulated Retained Earnings (Deficit)

-$327,735,000 (-6.13%)

-$308,819,000 (-28.80%)

-$239,774,000 (-18.20%)

-$202,857,000 (-12.89%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$3,077,000 (0.00%)

$3,077,000 (0.00%)

$3,077,000 (0.00%)

$3,077,000 (0.00%)

Total Debt

$126,515,000 (5.10%)

$120,371,000 (146.59%)

$48,815,000 (28.50%)

$37,989,000 (188.89%)

Debt Current

$43,385,000 (357.60%)

$9,481,000 (-44.27%)

$17,011,000 (1027.30%)

$1,509,000 (-33.61%)

Debt Non-Current

$83,130,000 (-25.03%)

$110,890,000 (248.67%)

$31,804,000 (-12.82%)

$36,480,000 (235.39%)

Total Liabilities

$134,456,000 (3.09%)

$130,428,000 (118.27%)

$59,754,000 (34.67%)

$44,371,000 (114.78%)

Liabilities Current

$48,249,000 (193.11%)

$16,461,000 (-33.82%)

$24,873,000 (416.68%)

$4,814,000 (-28.20%)

Liabilities Non-Current

$86,207,000 (-24.36%)

$113,967,000 (226.73%)

$34,881,000 (-11.82%)

$39,557,000 (183.48%)

ARMP Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$5,174,000 (14.24%)

$4,529,000 (-17.77%)

$5,508,000 (23.11%)

$4,474,000 (443.62%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$13,184,000 (13.18%)

$11,649,000 (56.64%)

$7,437,000 (-10.19%)

$8,281,000 (3.95%)

Research & Development Expense

$34,426,000 (1.94%)

$33,770,000 (-3.56%)

$35,017,000 (74.95%)

$20,015,000 (38.57%)

Operating Expenses

$47,610,000 (4.82%)

$45,419,000 (6.98%)

$42,454,000 (50.04%)

$28,296,000 (26.27%)

Interest Expense

$10,742,000 (309.06%)

$2,626,000 (0%)

$0 (0%)

$64,000 (-89.81%)

Income Tax Expense

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$18,916,000 (72.60%)

-$69,045,000 (-87.03%)

-$36,917,000 (-59.43%)

-$23,155,000 (-4.39%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$18,916,000 (72.60%)

-$69,045,000 (-87.03%)

-$36,917,000 (-59.43%)

-$23,155,000 (-4.39%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$18,916,000 (72.60%)

-$69,045,000 (-87.03%)

-$36,917,000 (-59.43%)

-$23,155,000 (-4.39%)

Weighted Average Shares

$36,160,848 (0.24%)

$36,075,555 (5.19%)

$34,294,124 (42.27%)

$24,104,146 (46.84%)

Weighted Average Shares Diluted

$59,059,971 (63.71%)

$36,075,555 (5.19%)

$34,294,124 (42.27%)

$24,104,146 (46.84%)

Earning Before Interest & Taxes (EBIT)

-$8,174,000 (87.69%)

-$66,419,000 (-79.91%)

-$36,917,000 (-59.88%)

-$23,091,000 (-7.14%)

Gross Profit

$5,174,000 (14.24%)

$4,529,000 (-17.77%)

$5,508,000 (23.11%)

$4,474,000 (443.62%)

Operating Income

-$42,436,000 (-3.78%)

-$40,890,000 (-10.68%)

-$36,946,000 (-55.09%)

-$23,822,000 (-10.35%)

ARMP Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$1,879,000 (76.90%)

-$8,134,000 (-267.89%)

-$2,211,000 (-69.56%)

-$1,304,000 (-58.25%)

Net Cash Flow from Financing

$34,958,000 (-35.25%)

$53,988,000 (22.66%)

$44,016,000 (72.49%)

$25,518,000 (9.94%)

Net Cash Flow from Operations

-$37,551,000 (20.82%)

-$47,423,000 (-46.00%)

-$32,481,000 (-37.78%)

-$23,575,000 (-29.04%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$4,472,000 (-185.02%)

-$1,569,000 (-116.83%)

$9,324,000 (1359.15%)

$639,000 (-84.48%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Capital Expenditure

-$1,879,000 (76.90%)

-$8,134,000 (-267.89%)

-$2,211,000 (-69.56%)

-$1,304,000 (-58.25%)

Issuance (Repayment) of Debt Securities

$34,889,000 (-35.42%)

$54,026,000 (0%)

$0 (0%)

$0 (0%)

Issuance (Purchase) of Equity Shares

$130,000 (2500.00%)

$5,000 (-99.99%)

$44,516,000 (65.29%)

$26,932,000 (16.79%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$2,893,000 (208.42%)

$938,000 (-69.79%)

$3,105,000 (7.74%)

$2,882,000 (-17.06%)

Depreciation Amortization & Accretion

$1,325,000 (36.32%)

$972,000 (8.97%)

$892,000 (-23.70%)

$1,169,000 (4.94%)

ARMP Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

Profit Margin

-365.60% (76.02%)

-1524.50% (-127.47%)

-670.20% (-29.51%)

-517.50% (80.80%)

EBITDA Margin

-132.40% (90.84%)

-1445.10% (-120.96%)

-654.00% (-33.47%)

-490.00% (80.27%)

Return on Average Equity (ROAE)

37.50% (-99.61%)

9653.30% (12936.84%)

-75.20% (9.29%)

-82.90% (0.36%)

Return on Average Assets (ROAA)

-18.30% (72.10%)

-65.60% (-76.34%)

-37.20% (14.29%)

-43.40% (12.50%)

Return on Sales (ROS)

-158.00% (89.23%)

-1466.50% (-118.82%)

-670.20% (-29.86%)

-516.10% (80.29%)

Return on Invested Capital (ROIC)

-7.00% (85.57%)

-48.50% (-16.87%)

-41.50% (15.48%)

-49.10% (39.01%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-3.56 (-109.79%)

-1.7 (-47.74%)

-1.15 (79.89%)

-5.71 (-158.16%)

Price to Sales Ratio (P/S)

12.93 (-49.90%)

25.81 (234.26%)

7.72 (-73.85%)

29.52 (-50.41%)

Price to Book Ratio (P/B)

-1.39 (61.83%)

-3.65 (-394.04%)

1.24 (-78.75%)

5.84 (97.47%)

Debt to Equity Ratio (D/E)

-2.8 (31.17%)

-4.07 (-345.65%)

1.66 (-5.21%)

1.75 (59.40%)

Earnings Per Share (EPS)

-0.52 (72.77%)

-1.91 (-76.85%)

-1.08 (-12.50%)

-0.96 (28.89%)

Sales Per Share (SPS)

0.14 (13.49%)

0.13 (-21.74%)

0.16 (-13.44%)

0.19 (272.00%)

Free Cash Flow Per Share (FCFPS)

-1.09 (29.22%)

-1.54 (-52.17%)

-1.01 (1.94%)

-1.03 (11.26%)

Book Value Per Share (BVPS)

-1.33 (-49.38%)

-0.89 (-184.51%)

1.05 (-0.19%)

1.05 (-8.27%)

Tangible Assets Book Value Per Share (TABVPS)

2.29 (-12.78%)

2.63 (-2.34%)

2.69 (-2.07%)

2.75 (25.28%)

Enterprise Value Over EBIT (EV/EBIT)

-23 (-666.67%)

-3 (-200.00%)

-1 (83.33%)

-6 (-200.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-26.96 (-777.86%)

-3.07 (-109.05%)

-1.47 (78.16%)

-6.73 (-165.57%)

Asset Turnover

0.05 (16.28%)

0.04 (-21.82%)

0.06 (-34.52%)

0.08 (366.67%)

Current Ratio

0.23 (-79.88%)

1.16 (6.99%)

1.09 (-65.10%)

3.12 (92.52%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$39,430,000 (29.03%)

-$55,557,000 (-60.14%)

-$34,692,000 (-39.44%)

-$24,879,000 (-30.30%)

Enterprise Value (EV)

$184,643,674 (-8.12%)

$200,961,900 (279.72%)

$52,923,435 (-64.11%)

$147,470,919 (184.84%)

Earnings Before Tax (EBT)

-$18,916,000 (72.60%)

-$69,045,000 (-87.03%)

-$36,917,000 (-59.43%)

-$23,155,000 (-4.39%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$6,849,000 (89.54%)

-$65,447,000 (-81.67%)

-$36,025,000 (-64.33%)

-$21,922,000 (-7.26%)

Invested Capital

$146,442,000 (-18.43%)

$179,540,000 (88.05%)

$95,474,000 (8.54%)

$87,965,000 (178.18%)

Working Capital

-$36,941,000 (-1473.27%)

$2,690,000 (23.74%)

$2,174,000 (-78.65%)

$10,181,000 (145.86%)

Tangible Asset Value

$82,947,000 (-12.57%)

$94,873,000 (2.74%)

$92,344,000 (39.33%)

$66,278,000 (83.97%)

Market Capitalization

$66,938,674 (-42.84%)

$117,114,900 (161.30%)

$44,819,435 (-69.80%)

$148,432,919 (165.90%)

Average Equity

-$50,400,750 (-6946.59%)

-$715,250 (-101.46%)

$49,121,750 (75.78%)

$27,945,750 (4.87%)

Average Assets

$103,335,750 (-1.85%)

$105,278,750 (5.95%)

$99,366,000 (86.11%)

$53,391,250 (19.47%)

Invested Capital Average

$116,994,250 (-14.52%)

$136,862,000 (53.69%)

$89,050,250 (89.49%)

$46,995,500 (75.48%)

Shares

36,183,067 (0.10%)

36,146,574 (0.01%)

36,144,706 (33.44%)

27,086,299 (44.83%)